Treatment of Relapsed Refractory CLL With Venetoclax-Rituximab During the COVID-19 Pandemic: A Daily-Life Experience in Southern Italy. Mediterr J Hematol Infect Dis 2021, 13 (1), e2021042. https://doi.org/10.4084/MJHID.2021.042.